Summary
LIBRA PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.2m and a net result of €137,007. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 35% of 6,680 sector peers (NACE 64, financial year 2025). The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Activities of holding companies
NACE 64210Retail sale of pharmaceutical products NACE 47730
10th largest company by total assets in Boechout, Finance and insurance sector1 site
Size
≈ €280,000turnover 2025, estimated
- Staff
- 0.8 FTE
- Equity
- €1.2m
- Profit
- €137,007
Turnover estimated from the gross margin
Financial health
Financial institution: outside the modelBankruptcy probability: sector outside the model
Structure
- Holdings
- 2
- Esmoreit De NeefDirector
- BYTEBIER KaatjeDirector
2025 accounts 24 days early2 of 4 deeds summarised
SignalsneutralLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Bankruptcy probability, 12 months
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 days early
2024
on the day
2023
30 days late
2022
31 days late
2021
60 days late
2020
31 days late
2019
52 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 26 days after the deadline; the sector median (NACE 64) for financial year 2024 is 14 days before the deadline, and 28% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · abbreviated…
- Appointment: Esmoreit De Neef (director)Gazette deed
Financials · financial year 2025, abbreviated format
Equity
€1.2m▲ 13.0%
2024 · €1.1m
Net result
€137,007▲ 215%
2024 · €43,462
Total assets
€3.6m▲ 117%
2024 · €1.6m
Solvency
33.3%▼ 30.7pp
2024 · 64.0%
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result recovers in 2025; 2025 is 66% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.1m
2025
Net result€0.1m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€3.6m
2025
Equity€1.2m
2025
Debt€2.4m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital-€0.6m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)3.8%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency33.3%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio0.16
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 64, Financial service activities, except insurance and pension funding: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.1m-€0.1m▼ 3.2%€0.2m▲ 39.3%€0.2m▲ 51.3%€0.2m▼ 3.2%€0.08m▼ 66.3%€0.07m▼ 19.0%€0.1m▲ 65.6%
Net result€0.05m-€0.05m▼ 10.6%€0.08mwithin the sector's middle half▲ 77.1%€0.1mwithin the sector's middle half▲ 70.1%€0.1mwithin the sector's middle half▲ 0.6%€0.05mwithin the sector's middle half▼ 63.7%€0.04mwithin the sector's middle half▼ 16.9%€0.1mwithin the sector's middle half▲ 215%
Equity€0.5m-€0.6m▲ 8.9%€0.7mwithin the sector's middle half▲ 14.4%€0.8mwithin the sector's middle half▲ 21.5%€1.0mwithin the sector's middle half▲ 17.8%€1.0mwithin the sector's middle half▲ 5.5%€1.1mwithin the sector's middle half▲ 4.3%€1.2mwithin the sector's middle half▲ 13.0%
Total assets€1.6m-€1.6m▼ 0.5%€1.6mwithin the sector's middle half▲ 2.5%€1.7mwithin the sector's middle half▲ 5.8%€1.7mwithin the sector's middle half▲ 0.2%€1.7mwithin the sector's middle half▼ 2.7%€1.6mwithin the sector's middle half▼ 2.2%€3.6mwithin the sector's middle half▲ 117%
Debt€1.1m-€1.0m▼ 5.2%€1.0m▼ 4.4%€0.9m▼ 5.2%€0.8m▼ 15.4%€0.7m▼ 12.7%€0.6m▼ 11.9%€2.4m▲ 302%
Working capital-€0.2m--€0.2m▼ 18.8%-€0.2mbelow the sector's middle half▲ 2.9%-€0.4mbelow the sector's middle half▼ 105%-€0.3mbelow the sector's middle half▲ 19.1%-€0.4mbelow the sector's middle half▼ 14.7%-€0.4mbelow the sector's middle half▼ 12.6%-€0.6mbelow the sector's middle half▼ 46.6%
Solvency33.6%-36.8%▲ 3.2pp41.0%within the sector's middle half▲ 4.3pp47.1%within the sector's middle half▲ 6.1pp55.4%within the sector's middle half▲ 8.2pp60.0%within the sector's middle half▲ 4.6pp64.0%within the sector's middle half▲ 4.0pp33.3%within the sector's middle half▼ 30.7pp
Current ratio0.44-0.38▼ 0.060.46within the sector's middle half▲ 0.080.39within the sector's middle half▼ 0.070.45within the sector's middle half▲ 0.050.37within the sector's middle half▼ 0.080.30below the sector's middle half▼ 0.070.16below the sector's middle half▼ 0.14
Return on assets (ROA)3.3%-3.0%▼ 0.3pp5.2%within the sector's middle half▲ 2.2pp8.3%within the sector's middle half▲ 3.1pp8.4%within the sector's middle half=3.1%within the sector's middle half▼ 5.2pp2.6%within the sector's middle half▼ 0.5pp3.8%within the sector's middle half▲ 1.2pp
Staff (FTE)0.8within the sector's middle half
above
within
below
the middle half of NACE 64, Financial service activities, except insurance and pension funding: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.6m
Fixed assets
€3.5m ▲ 134%
Current assets
€113,071 ▼ 33.0%
Equity and liabilities €3.6m
Equity
€1.2m ▲ 13.0%
Debt
€2.4m ▲ 302%
Debt's share of the balance-sheet total rises from 36.0% to 66.7%. Equity and debt are higher.
Key figures and ratios
ROE
11.5%▲
2024 · 4.1%
Debt ≤ 1 year
€699,747▲
2024 · €568,998
Debt > 1 year
€1.7m▲
2024 · €22,426
Income taxes
€33,526▲
2024 · €22,333
Staff costs
€51,858
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | - | - | - | - | €51,858 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | - | €105 | €2,371 | €3,072 | €3,512 | €13,599 | ▲ 287% |
| Other operating charges640/8 | - | - | - | €1,789 | €2,197 | €2,126 | €2,545 | €4,773 | ▲ 87.6% |
| Gross operating margin9900 | €122,076 | €119,722 | €164,732 | €248,148 | €242,875 | €85,579 | €71,160 | €178,051 | ▲ 150% |
| Operating profit (loss)9901 | €120,629 | €116,812 | €162,730 | €246,254 | €238,308 | €80,382 | €65,103 | €107,820 | ▲ 65.6% |
| Financial income75/76B | - | - | - | €935 | €5,187 | €9,785 | €8,200 | €104,491 | ▲ 13× |
| Recurring financial income75 | €2,421 | €1,512 | €1,411 | €935 | €5,187 | €9,785 | €8,200 | €104,491 | ▲ 13× |
| Financial charges65/66B | - | - | - | €35,155 | €29,778 | €10,760 | €7,508 | €41,778 | ▲ 456% |
| Recurring financial charges65 | €38,487 | €38,455 | €38,155 | €35,155 | €29,778 | €10,760 | €7,508 | €41,778 | ▲ 456% |
| Profit (loss) for the period before taxes9903 | €84,563 | €76,626 | €125,986 | €212,033 | €213,717 | €79,407 | €65,795 | €170,533 | ▲ 159% |
| Income taxes67/77 | €31,321 | €29,046 | €41,706 | €68,674 | €69,485 | €27,099 | €22,333 | €33,526 | ▲ 50.1% |
| Profit (loss) for the period9904 | €53,242 | €47,580 | €84,280 | €143,359 | €144,233 | €52,308 | €43,462 | €137,007 | ▲ 215% |
| Profit (loss) for the period to be appropriated9905 | €53,242 | €47,580 | €84,280 | €143,359 | €144,233 | €52,308 | €43,462 | €137,007 | ▲ 215% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €1.6m | €1.6m | €1.6m | €1.7m | €1.7m | €1.7m | €1.6m | €3.6m | ▲ 117% |
| Fixed assets21/28 | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €3.5m | ▲ 134% |
| Tangible fixed assets22/27 | - | - | - | €0.004m | €0.005m | €0.005m | €0.005m | €0.08m | ▲ 18× |
| Plant, machinery and equipment23 | - | - | - | - | €0.002m | €0.001m | €0.003m | €0.002m | ▼ 28.4% |
| Furniture and vehicles24 | - | - | - | €0.004m | €0.004m | €0.004m | €0.002m | €0.008m | ▲ 395% |
| Leasing and similar rights25 | - | - | - | - | - | - | - | €0.07m | - |
| Financial fixed assets28 | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €1.5m | €3.4m | ▲ 129% |
| Current assets29/58 | €0.1m | €0.1m | €0.2m | €0.2m | €0.3m | €0.2m | €0.2m | €0.1m | ▼ 33.0% |
| Amounts receivable within one year40/41 | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | €0.2m | €0.1m | €0.1m | ▼ 25.8% |
| Trade receivables40 | - | - | - | €0.1m | €0.05m | €0.02m | €0.02m | €0.05m | ▲ 211% |
| Other amounts receivable41 | - | - | - | €0.09m | €0.2m | €0.1m | €0.1m | €0.06m | ▼ 56.3% |
| Cash at bank and in hand54/58 | €0.008m | €0.02m | €0.03m | €0.02m | €0.02m | €0.04m | €0.02m | €0.005m | ▼ 81.5% |
| Deferred charges and accrued income490/1 | - | - | - | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | ▲ 61.2% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €1.6m | €1.6m | €1.6m | €1.7m | €1.7m | €1.7m | €1.6m | €3.6m | ▲ 117% |
| Equity10/15 | €0.5m | €0.6m | €0.7m | €0.8m | €1.0m | €1.0m | €1.1m | €1.2m | ▲ 13.0% |
| Contributions10/11 | €0.01m | €0.01m | - | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Reserves13 | €0.5m | €0.6m | €0.6m | €0.8m | €0.9m | €1.0m | €1.0m | €1.2m | ▲ 13.8% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | €0.002m | €0 | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | €0.002m | €0 | - | - | - |
| Distributable reserves133 | - | - | - | €0.8m | €0.9m | €1.0m | €1.0m | €1.2m | ▲ 13.8% |
| Profit (loss) carried forward14 | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | €0 | ▼ 100% |
| Amounts payable17/49 | €1.1m | €1.0m | €1.0m | €0.9m | €0.8m | €0.7m | €0.6m | €2.4m | ▲ 302% |
| Amounts payable after more than one year17 | €0.8m | €0.7m | €0.6m | €0.3m | €0.2m | €0.1m | €0.02m | €1.7m | ▲ 74× |
| Financial debts170/4 | - | - | - | €0.3m | €0.2m | €0.1m | €0.02m | €1.7m | ▲ 74× |
| Amounts payable within one year42/48 | €0.3m | €0.3m | €0.3m | €0.6m | €0.6m | €0.6m | €0.6m | €0.7m | ▲ 23.0% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.08m | €0.08m | €0.09m | €0.09m | €0.1m | ▲ 67.3% |
| Financial debts43 | - | - | - | - | - | - | - | €0.002m | - |
| Credit institutions430/8 | - | - | - | - | - | - | - | €0.002m | - |
| Trade debts44 | €371 | €0.001m | €0.001m | €0.007m | €0.002m | €0.002m | €0.002m | €0.009m | ▲ 388% |
| Suppliers440/4 | - | - | - | €0.007m | €0.002m | €0.002m | €0.002m | €0.009m | ▲ 388% |
| Taxes, remuneration and social security45 | - | - | - | €0.02m | €0.02m | €0.005m | €0.009m | €0.08m | ▲ 716% |
| Taxes450/3 | - | - | - | €0.02m | €0.02m | €0.005m | €0.009m | €0.05m | ▲ 475% |
| Remuneration and social security454/9 | - | - | - | - | - | - | - | €0.02m | - |
| Other amounts payable47/48 | - | - | - | €0.5m | €0.5m | €0.5m | €0.5m | €0.5m | ▼ 0.9% |
| Accrued charges and deferred income492/3 | - | - | - | €341 | €0.01m | €0.001m | €410 | €0.009m | ▲ 21× |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.05m | €0.05m | €0.08m | €0.1m | €0.1m | €0.05m | €0.04m | €0.1m | ▲ 215% |
| + Depreciation and write-downs630 | - | - | - | €105 | €0.002m | €0.003m | €0.004m | €0.01m | ▲ 287% |
| Operating cash flow (approximation) | €0.05m | €0.05m | €0.08m | €0.1m | €0.1m | €0.06m | €0.05m | €0.2m | ▲ 221% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€0.004m | -€0.003m | -€0.003m | -€0.003m | -€2.0m | ▼ 57,319% |
| Change in cash | - | €0.01m | €0.01m | -€0.009m | €0.003m | €0.02m | -€0.01m | -€0.02m | ▼ 38.2% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 14 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 07-07-2026 | 2026-00260854 |
| 31-12-2024 | abbreviated format | 31-07-2025 | 2025-00339282 |
| 31-12-2023 | abbreviated format | 30-08-2024 | 2024-00404093 |
| 31-12-2022 | abbreviated format | 31-08-2023 | 2023-00387364 |
| 31-12-2021 | abbreviated format | 29-09-2022 | 2022-20439657 |
| 31-12-2020 | abbreviated format | 31-08-2021 | 2021-58000205 |
| 31-12-2019 | abbreviated format | 21-09-2020 | 2020-54000497 |
| 31-12-2018 | abbreviated format | 01-07-2019 | 2019-25100165 |
| 31-12-2017 | abbreviated format | 28-06-2018 | 2018-23700182 |
| 31-12-2016 | micro format | 13-07-2017 | 2017-30300007 |
Similar companies · same sector, comparable size
GRYP JIMMY
BE 0635.687.916
Assenede · equity €1,187,848
ANFI
BE 0447.279.569
Brugge · equity €1,187,893
HUZAAR HOLDING
BE 1005.073.616
Deinze · equity €1,187,906
DINOIS
BE 0808.544.092
Beveren-Kruibeke-Zwijndrecht · equity €1,187,920
Sterling Partners
BE 0799.155.977
Sint-Martens-Latem · equity €1,187,393
Of the 24,455 active companies whose main activity is activities of holding companies (NACE 64210), figures are known for 20,128. 12,354 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
2 directors, last change in 2024
Esmoreit De Neef
CurrentDirector (not named in the articles) · since 01-07-2024
BYTEBIER Kaatje
CurrentDirector
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 4 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2023, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| BYTEBIER Kaatje |
|
| Esmoreit De Neef |
|
Owners and capital
Capital and shareholders
Capital over the years
- 25-08-2023 Capital stated in the deed · 186 shares
Group and network
Holdings and subsidiaries
2 holdingsHoldings 2
Source for every holding own accounts 2025
- APOTHEEK SINT BAVOsubsidiaryEquity €421,156Result €22,355100%
- BYTEBIER KAATJEsubsidiaryEquity €599,226Result €21,665100%
According to the 2025 annual accounts of LIBRA PHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
2 current directorsThe board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Board mandates elsewhere
2 board mandatesBoard mandates of this companythis company sits on their board2
1 location
1 location
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
17-10
Gazette deed
Appointment: Esmoreit De Neef (director)2 facts ▸
Gazette deed
Appointment: Esmoreit De Neef (director)
2 facts ▸
- General meeting, 01-07-2024
- Director appointment, Esmoreit De Neef (director (not named in the articles))
30-08
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 30 days late
2023
31-12
Financial
Equity above €1mequity €1.0m ▲5.5%
A profit in every financial year since 2018 builds equity to €1.0m.
31-08
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 31 days late
25-08
Gazette deed
Reappointment: BYTEBIER Kaatje (director)Amendment of the articles · Capital conversion · Reserve release9 facts ▸
Gazette deed
Reappointment: BYTEBIER Kaatje (director)
Amendment of the articles · Capital conversion · Reserve release9 facts ▸
- General meeting, 18-08-2023
- Amendment of the articles (2 times)
- Capital conversion, EUR, “eigen vermogensrekening “niet-opgevraagde inbrengen”” (deed in Dutch)
- Reserve release, “statutair onbeschikbare eigen vermogensrekening geheel opheffen en middelen beschikbaar maken voor uitkering, alle eigen vermogensbestanddelen beschikbaar” (deed in Dutch)
- Legal-form conversion, “besloten vennootschap” (deed in Dutch)
- Capital
- Director reappointment, BYTEBIER Kaatje (director)
- Registered office clause, “2531 Boechout,Vremdesesteenweg 259” (deed in Dutch)
- Other provision, “verklaring enige aandeelhouder, enige aandeelhouder” (deed in Dutch)
2022
31-12
Financial
Highest result from 2018 to 2025net €144,233 ▲0.6%
Net result €144,233, the highest in the series.
29-09
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 60 days late
2021
31-08
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 31 days late
2020
21-09
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 52 days late
2019
01-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
13-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
2 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPrivate limited company
Founded16-02-2011
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID
0208:0833903555
Also
9925:BE0833903555
Registered
18-09-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Boechout · 1 establishment unit since 2011
Ground area
1,152 m²
Building footprint
243 m²
Building volume
284 m³
Parcel 11047B0067/00P003, Flanders · tallest building 7.7 m. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Libra Pharma
since 2011unit no. 2.196.649.528
1 parcel
Flanders
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11047B0067/00P003 | Flanders | 1,152 m² | 1 · 243 m² | 7.7 m |
How the parcels are linked
Good to know
The parcel matches the address exactly.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Libra Pharma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Elke bestuurder bevoegd alle handelingen te verrichten nodig of dienstig tot verwezenlijking voorwerp,tenzij waarvoor volgens wet algemene…” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Inzake overdracht van aandelen gelden de in de statuten opgelegde regelingen” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “De vennootschap wordt, binnen hun bevoegdheidssfeer, tevens rechtsgeldig vertegenwoordigd door de personen belast met het dagelijks bestuur…” (deed in Dutch)
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Ontbinding, algemene vergadering bepaalt wijze overeenkomstig wettelijke bepalingen” (deed in Dutch)